Average Co-Inventor Count = 3.04
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Acetylon Pharmaceuticals, Inc. (18 from 35 patents)
2. Regenacy Pharmaceuticals, LLC (12 from 16 patents)
3. Novartis Ag (9 from 3,923 patents)
4. Inotek Pharmaceuticals Corporation (5 from 37 patents)
5. Ciba-geigy Corporation (3 from 6,850 patents)
6. Activbiotics, Inc. (3 from 6 patents)
7. Activbiotics Pharma, LLC (3 from 4 patents)
8. Mersana Therapeutics, Inc. (1 from 36 patents)
9. Novartis Pharma Gmbh (8 patents)
54 patents:
1. 11858919 - HDAC1,2 inhibitors
2. 11702389 - Piperidine derivatives as HDAC1/2 inhibitors
3. 11617750 - Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
4. 11542242 - Substituted piperazines as selective HDAC1,2 inhibitors
5. 10968180 - Piperidine derivatives as HDAC1/2 inhibitors
6. 10927072 - Phenyl and pyridinyl hydroxamic acids
7. 10774056 - Substituted piperazines as selective HDAC1,2 inhibitors
8. 10464906 - Crystalline forms of a histone deacetylase inhibitor
9. 10385031 - Substituted piperazines as selective HDAC1,2 inhibitors
10. 10370324 - Phenyl and pyridinyl hydroxamic acids
11. 10358421 - Piperidine derivatives as HDAC1/2 inhibitors
12. 10239837 - Piperidine derivatives as HDAC1/2 inhibitors
13. 10144714 - Methods of making protein deacetylase inhibitors
14. 10125131 - Selective HDAC3 inhibitors
15. 9957259 - Selective HDAC1 and HDAC2 inhibitors